Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
85 studies found for:    IPF | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
2 Recruiting Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
3 Not yet recruiting Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis
Intervention:
4 Recruiting Treatment of IPF With Laparoscopic Anti-Reflux Surgery
Conditions: Idiopathic Pulmonary Fibrosis;   Gastroesophageal Reflux
Intervention: Procedure: Surgery
5 Recruiting Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis
Condition: Ambulatory IPF
Interventions: Drug: Rituximab;   Drug: Placebo
6 Recruiting The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Cough monitor
7 Recruiting Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
8 Recruiting Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention:
9 Recruiting Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: No Intervention
10 Recruiting Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
Condition: IPF
Intervention:
11 Unknown  Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients
Conditions: Idiopathic Pulmonary Fibrosis;   Cough;   Breathlessness
Intervention: Behavioral: Cognitive behavioural therapy
12 Recruiting Study in Subjects With PAH and PH Secondary to IPF Using Inhaled NITROsyl
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis
Intervention: Drug: Inhaled Nitric Oxide
13 Recruiting A Validation and Dosimetry Study of GSK2634673F PET Ligand
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: GSK2634673F
14 Recruiting Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Cotrimoxazole;   Drug: Placebo
15 Recruiting STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Interventions: Drug: BG00011;   Drug: Placebo
16 Unknown  The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Condition: IDIOPATHIC PULMONARY FIBROSIS
Intervention:
17 Recruiting RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Inhaled TD139;   Drug: Placebo
18 Recruiting Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
19 Recruiting A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: GSK2126458;   Drug: Placebo
20 Recruiting A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Simtuzumab (GS-6624);   Drug: Placebo to match simtuzumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years